Skip to main content
Caplight Logo









Wavepaths

Wavepaths

Private
LondonHealthcare & Life Scienceshttps://wavepaths.com/

Last Round

Seed

Nov 2, 2021

Total Funding Raised

$4.94M

Company Overview

Wavepaths operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in November 2021.

Wavepaths is a health technology company that provides a person-centred music platform designed to support psychedelic-assisted therapy and mental health care.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical AI, Clinical Trials, Personalization

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Wavepaths Comparables

Compare Wavepaths with similar companies based on industry and business-model similarity.

Wavepaths comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LUCID
77%
Entheo Digital
68%
TRIPP, Inc.
62%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Wavepaths Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 2, 2021
CrowdfundingDec 14, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Wavepaths Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 14, 2025

    Monthly visitors grew 63% MoM, reaching 10K.

  • May 1, 2025

    Monthly visitors increased 68% MoM, reaching 3.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Wavepaths Filings

Explore SEC and related filing metadata, where available.

Wavepaths filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Wavepaths's valuation, stock price, and market status.

Is Wavepaths a public or private company?

Wavepaths is a private company.

What is the current stock price of Wavepaths?

Wavepaths is a private company, so its shares have no public market price. Caplight tracks Wavepaths's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Wavepaths worth (valuation)?

Valuation information for Wavepaths is not publicly available.

Can I buy Wavepaths stock?

Wavepaths shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Wavepaths's last funding round?

Wavepaths's most recent funding round was Seed on November 2, 2021.

Who are the main investors in Wavepaths?

Key investors in Wavepaths include Lionheart Ventures, Bridge Builders Collaborative, Reflex Capital, Neo Kuma Ventures, Empath Ventures.

Will Wavepaths IPO soon?

No public IPO plans have been announced for Wavepaths.

How can I track Wavepaths secondary market activity?

Caplight tracks bids, offers, and trades in Wavepaths's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range7
Year Founded2016
Last FundingNov 2, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?